The combination of the positive rate of both CD43 and CD180 expression could increase the specificity of CLL diagnosis to 91.5% with a sensitivity of 62.4% using ROC curve analysis with a larger AUC of 0.85 (Figure 1E). This evidence concerns the gene SPN and B-cell chronic lymphocytic leukemia.